Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Lantern Pharma Inc
(NQ:
LTRN
)
4.330
-0.320 (-6.88%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 27, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Lantern Pharma Inc
< Previous
1
2
3
Next >
LTRN Stock Earnings: Lantern Pharma Beats EPS for Q2 2024
August 08, 2024
LTRN stock results show that Lantern Pharma beat analyst estimates for earnings per share the second quarter of 2024.
Via
InvestorPlace
12 Health Care Stocks Moving In Monday's After-Market Session
May 13, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
May 10, 2024
Via
Benzinga
LTRN Stock Earnings: Lantern Pharma Misses EPS for Q1 2024
May 09, 2024
LTRN stock results show that Lantern Pharma missed analyst estimates for earnings per share the first quarter of 2024.
Via
InvestorPlace
3 Machine Learning Stocks with the Potential to Make You an Overnight Millionaire
May 01, 2024
Keep an eye on machine learning stocks. With big demand, we could be looking at a half-trillion-dollar market by 2030.
Via
InvestorPlace
Recap: Lantern Pharma Q4 Earnings
March 18, 2024
Via
Benzinga
Lantern Pharma Earnings Preview
March 15, 2024
Via
Benzinga
Lantern Pharma: Q3 Earnings Insights
November 08, 2023
Via
Benzinga
Why Wang & Lee Group Shares Are Trading Higher By 38%; Here Are 20 Stocks Moving Premarket
April 19, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
April 11, 2024
Via
Benzinga
AI Sector Stalling: Only 4 Of 7 Categories Went Up In March
March 31, 2024
No AI category went down in February, but 3 did in March - confirming my comment last week that
Via
Talk Markets
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Six Of Seven AI Stock Categories Increased This Week
March 23, 2024
All but one of the 7 artificial intelligence stock categories that I analyze weekly increased in value this week. But two categories are still down MTD, suggesting that the surge in the artificial...
Via
Talk Markets
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
A Preview Of Lantern Pharma's Earnings
November 07, 2023
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
March 19, 2024
Via
Benzinga
LTRN Stock Earnings: Lantern Pharma Beats EPS for Q4 2023
March 18, 2024
LTRN stock results show that Lantern Pharma beat analyst estimates for earnings per share the fourth quarter of 2023.
Via
InvestorPlace
Earnings Scheduled For March 18, 2024
March 18, 2024
Companies Reporting Before The Bell • Niu Techs (NASDAQ:NIU) is expected to report earnings for its fourth quarter.
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
March 11, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
March 08, 2024
Via
Benzinga
Why United Natural Foods Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
March 06, 2024
Shares of United Natural Foods, Inc. (NYSE: UNFI) fell sharply during Wednesday’s session following second-quarter results.
Via
Benzinga
Box Reports Upbeat Earnings, Joins American Public Education, Wave Life Sciences And Other Big Stocks Moving Higher On Wednesday
March 06, 2024
U.S. stocks were higher, with the Dow Jones index gaining more than 200 points on Wednesday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
AI-Powered Drug Discovery Stocks Index Up 9% In February; Remains Down 8% YTD
March 04, 2024
Grand View Research says the global
Via
Talk Markets
3 AI Powerhouses Predicted to Soar 500% in the Next Tech Boom
February 20, 2024
Discover how these AI powerhouses are leveraging AI in the IT consulting, application software, and biotech industries.
Via
InvestorPlace
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
AI-Powered Drug Discovery Stocks Index Up 18% Last Week, Led By BioXcel Therapeutics
February 19, 2024
The AI-powered drug discovery market is projected to grow at a 30% CAGR between now and 2030, with annual sales in excess of $50 billion anticipated. An AI drug discovery revolution is underway.
Via
Talk Markets
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
AI-Focused Drug Discovery Stocks Index Up 26% In December
December 29, 2023
With the promise of lower costs and shorter development timelines, AI-enabled drug discovery holds massive potential to increase the accessibility of drugs and to treat presently incurable conditions.
Via
Talk Markets
12 Health Care Stocks Moving In Monday's Pre-Market Session
December 18, 2023
Via
Benzinga
AI-Focused Drug Discovery Stocks Index Up 10.6% Last Week
December 17, 2023
A new study concludes that the AI method of drug discovery is up to 250 times more efficient than the traditional method.
Via
Talk Markets
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
The 3 Most Undervalued AI Penny Stocks to Buy in December
December 13, 2023
These AI penny stocks offer substantial returns to investors as the market continues to grow at a rapid pace.
Via
InvestorPlace
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
12 Health Care Stocks Moving In Thursday's Intraday Session
November 09, 2023
Via
Benzinga
The 7 Most Undervalued AI Penny Stocks to Buy: October 2023
October 24, 2023
Unlock exponential growth with the next big undervalued AI penny stocks to buy, offering tremendous upside ahead.
Via
InvestorPlace
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
The 3 Most Undervalued Machine Learning Stocks to Buy in September 2023
September 14, 2023
Here are three machine-learning stocks that may be ready to move much higher when investor sentiment changes.
Via
InvestorPlace
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.